Supplementary - Combi-TED_-_Study_Protocol_v3.0_09.06.2022 (1).pdf (2.18 MB)
Combi-TED: a new trial testing Tedopi R with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line study protocol
dataset
posted on 2023-05-11, 16:40 authored by Lorenza Landi, Angelo Delmonte, Andrea Bonetti, Giulia Pasello, Giulio Metro, Francesca Mazzoni, Gloria Borra, Diana Giannarelli, Kalliopi Andrikou, Daniela Mangiola, Stefania Gori, Mario Rosario D’Andrea, Gabriele Minuti, Blerina Resuli, Anastasia Laudisi, Antonello Vidiri, Laura Conti, Federico CappuzzoCombi-TED: a new trial testing Tedopi R with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line study protocol